Blog Posts By Morgan Kervitsky

March 7, 2022

March Company Update

Dear friends, Colleagues and Shareholders, Mydecine has made strides towards our goals over the last few months! We continue to gain momentum as we reach significant milestones in our clinical trial…

Read More